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Summary Forty-two oral squamous cell carcinomas (SCCs) were analysed for p53 mutations and human papillomavirus (HPV) infection to
examine the prevalency of these factors and correlation with apoptotic index (Al; number of apoptotic cells per 100 tumour cells) of the tumour
tissue. In polymerase chain reaction (PCR)-Southem blot analysis. HPV DNAs were detected from 22 out of 42 SCCs (52%) with
predominance of HPV-16 (68%). p53 mutations in exons 5-8, screened by nested PCR-single-strand conformation polymorphism (PCR-
SSCP) analysis, were observed in 16 of 42 tumours (38%). The state of the p53 gene did not show any correlation with HPV infection. The
terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end labelling (TUNEL) method was used for detection of apoptotic
cells. The mean Al was 2.35, ranging from 0.31 to 6.63. SCCs associated with p53 mutation had significantly lower Al than those without p53
mutation (P< 0.01). whereas no difference in Al was found between SCCs with and without HPV infection. The results of this study confirmed
that HPV infection and/or p53mutations are implicated, but are not mutually exclusive events, in carcinogenesis of oral SCC and also showed
that decrease in apoptosis is more closely related to p53 mutation than HPV infection.
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Squamous cell carcinoma (SCC) is the most common malignant
neoplasm ofthe oral mucosa. representing more than 90% ofintra-
oral malignant tumours. Tobacco and alcohol use. viral infections.
nutritional deficiencv and dietary customs have all been impli-
cated in the aetiology ofhead and neck cancer (Regezi et al. 1993).
W'hereas the epidemiology has been w-ell described so far. the
molecular steps involsed in the pathogenesis of these common
neoplasms are poorly understood. The role of human papilloma-
s-irus (HPV) in the development of anogenital cancers has been
widely studied. and current evidence shows that HPV infection is
necessars for the desvelopment of most cervical cancers (zur
Hausen. 1994). Approximately 80-90% of cervical carcinomas
contain HPV DNA. and the predominant orhigh-risk types appear
to be HPV-16. -18 and -33 (Yoshikawa et al. 1991). HPV E6 and
E7 proteins. consistentlv expressed in HPV-transformed and HPV-
positive tumours. can exert their oncogenic potential bv inacti-
vating the products of the p53 tumour-suppressor cene (Lemine.
1990: zur Hausen. 1994) and the retimoblastoma (Rb) grene (Dy-son
et al. 1989). In oral malignant lesions. the state of HPV infection
has been reported to be as high as 76%c (Snijders et al. 1994).
although there are still conflicting results in infection rate and role
of HPV in oral carcinorenesis.
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p53 plays an important role in the maintenance of genomic
integrits through the induction of cell growth arrest or apoptosis
follossin, DNA damage (Weinberg. 1991: Smith et al. 1995). The
loss ofa functional tumour-suppressor protein such as p53 has been
implicated in the aetiolog- and progression of a variety of human
tumours (Levine. 1990: Hollstein et al. 1991a). Indeed. p53 muta-
tion is the most frequently detected genetic alteration in human
cancers. particularly in tobacco-related tumours ofthe lung. oesoph-
agus and oral cavity (Hollstein et al. 1991b). The loss of activity of
the wild-type p53 protein can be achiesed bv two different mecha-
nisms: eitherby a mutation ofthep53 gene (Crook et al. 1991 ) orby
binding to the HPV encoded E6 protein (Scheffner et al. 1990). In
oral cancer. both mechanisms ofinactivating p53 may play a role in
carcinogenesis. Several studies. analysing the relationship betu-een
p53 mutations and HPV infection in malignant head and neck
tumours. have shown high frequencies of p53 mutations in HPV-
positixe oral cancers (Brachman et al. 1992: Barten et al. 1995).
Apoptosis. orprogrammed cell death. is an essential mechanism
that regulates cell loss in tissue modellinc for vertebrate deselop-
ment with apparent differences from necrosis. This process is a
unique feature of multicellular organisms that enables continuous
renewal of tissue by cell division while maintaining the steadv-
state lesvel of the various histological compartments under tight
control (Raff. 1992). Regulation ofthe process leading to aphy sio-
logical cell death involhves expression of sexeral proto-oncogenes
or tumour-suppressor genes. such as c-mvc. bcl-2 andp53 (Clarke
et al. 1993). Failure oftumour cells to undergo apoptosis can result
in uncontrolled accumulation ofcells (Kerr et al. 1994).
Morphologically. apoptosis is characterized by nuclear chro-
matin condensation and budding, of the cell. with formation of
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Table 1 Detection of HPV DNA sequences with PCR-Southem blot analysis in oral squamous cell carcinomas
HPV negative HPV positive
16 18 33 16 and 18 16 and 33 Total
20 (47.6°o) 12 5 2 1 2 22 (52.40o)
Table 2 Detection of p53 mutations with nested PCR-SSCP analysis in oral squamous cell carcinomas
Wiki-type p53 Mutant p53
Exon 5 Exon 6 Exon 7 Exon 8 Exons 5 and 6 Exons 6 and 8 Total
26 (61.9°o) 4 2 4 3 2 1 16 (38.1°o)
A
1 2 3 4 5 7 9
-E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 7~ ~~~~~~~~~~~~~~~~~~
B
C
1 2 3 4 5 6 7 8 9 H (+)
1 2 3 4 5 6 7 8 9 H (+)
Figure 1 Detection of the HPV DNA sequences in oral squamous-cell
carcinomas by PCR-Southem blot analysis. A, B and C show the resufts for
amplified HPV DNA type 16. 18 and 33 respectivety. (-). Negative controls:
(+). HPV-positive controls
membrane-enclosed apoptotic bodies containinc well-preserved
or2anelles. which are phagocvtosed and digested by nearby resi-
dent cells (Kerr et al. 1972: Wxllie et al. 1984). Because of the
short duration of morphological changes and seemingly low
incidence. it is difficult to detect apoptosis in routine histological
sections. Such difficulties can be o-ercome by using the terminal
deoxx-nucleotidx 1 transferase (TdT)-mediated dUITP-biotin nick
end labelling (TUNEL) method. which detects apoptosis by in situ
labelling, of DNA breaks in indi-idual nuclei in tissue sections
processed throurh the routine procedures ofhistopathologx.
Recently. there has been growing interest in apoptosis in relation
to histopathological differentiation. tumour progression and its
prognostic value (Kasagi et al. 1994: Tormainen et al. 1995). There
is. howexer. no report axailable so far on the significance of apo-
ptosis in oral cancer in relation top53 mutation and/or HPV infec-
tion. Therefore. we exaluated the pre-alence of HPV infection and
p53 mutations in individuals with malignant oral lesions and exam-
ined the relationship of these factors w-ith apoptotic index (Al) of
the tumour tissue.
MATERIALS AND METHODS
Forty-two cases of oral SCC were collected from the 1989-1996
pathological files of Chonbuk National University Hospital and
examined by light microscopy using sections stained routineiv
with haematoxy lin and eosin (H&E). Tissue sections containing
more than 20% tumour tissue w-ere used: verrucous carcinoma w-as
not included in this studv.
Extraction of DNA from paraffin-embedded tissue
Several 10-gm-thick paraffim-embedded sections x-ere collected
into 1.5-ml microcentrifuge tubes. The instruments A-ere sterilized
with 5%C/ sodium hypochlorite solution. and care w-as taken to avoid
cross-contamination of the samples. After deparaffinization and
hvdration. samples were l-sed in 1 ml of lOmMi Tris-HCI
(pH 8.0). 0.1 _I NaCl. 10 mMI EDTA. 0.5% sodium dodecyl sulphate
(SDS) and0.5 mg ml-' proteinase K at 37C for24 h. The DNA A-as
extracted wxith phenol-chloroform-isoamv,lalcohol (50:49:1).
precipitated by ethanol. air dried and redissolved in 10 mm Tris-
HCI. 1 mis\ EDTA (pH 8.0) at a concentration of0.1 tg 1l-'
Detection of HPV DNA by PCR-Southern blot
HPV DNA sequences %vere amplified by PCR to generate DNA
fragments x ithin the open reading frames ofE6 using fourpnrmers
specific for HPV-16. -18 and -33 as descnrbed by Shimada et al
(1990). The PCR reaction x-as carried out in 20 pl of a reaction
mixture containing 2'00-4 ng of genomic DNA. 50 mn\ KCI.
10mrm Tris-HCl (pH 8.3). 1.5 mm MgCl,. 0.01%c (x-/v) gelatin.
0.2 mmn of each dNTPs. 20 pmol of each primer and 0.5 units of
Taq DNA poly merase (Takara Shuzo Co.. Japan). The reaction
mixtures were subjected to 35 cycles of amplification under the
following conditions: denaturation for 1 min at 95-C. annealinr
for 2 min at 55'C and extension for 2 min at 72-C. The cycling
w-as preceded by 5 min at 953C and finished by an additional
extension for 10 min at 72:C. Knowxn HPV-positive and -neratixe
controls from cervical carcinoma and 'no template' negatixve
controls were utilized for all amplifications.
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A
wt 1 2 3 4 5 6 7 8
C
wt 1 2 3 4 5 6 7 8
wt 1 2 3 4 5 6 7 8
D
wt 1 2 3 4 5 6 7 8
Figure 2 Detection of p53 gene mutations in oral squamous-cell carcinomas by nested PCR-SSCP analysis. Wild-type (wt) control in each exon is also shown
for comparison. Mobility shifts of the band (arrows) are noted on lane 8 in A, lanes 1 and 4 in B. lane 6 in C. and lanes 1. 6 and 7 in D. A. B. C and D show the
results for amplified exons 5. 6, 7 and 8 respectively
After amplification. 10 jil ofthe PCR products was subjected to
electrophoresis through 2% agarose gel and transferred to nylon
membrane (Hybond-N-. Amersham. UK) with an alkaline buffer
(0.4Mi NaOH). The membranes were hybridized at 42CC with
oligonucleotide probes specific for E6 of HPV-16. -18 and -33.
which were 5' end-labelled with [r- P]ATP (> 3000 Ci mmol-'.
Amersham) and T4 polvnucleotide kinase (Takara Schuzo Co.).
For visualization of the hybridization results. membranes were
exposed to Agfa X-ray film with an intensifying screen at - 70'C
for 18-24 h.
Analysis of p53 mutations by nested PCR-SSCP
Exons 5-8 ofthep53 gene were analysed for the presence of muta-
tions using nested PCR amplification followed by SSCP analysis
(Orita et al. 1989). The oligonucleotide primers for exons 5-6. 5.
6. 7. 8 (outer). and 8 (inner) were prepared according to the
sequence published by Buchman et al (1988). In the present study.
the nested PCR method wvas used to overcome a difficulty in
amplification of DNA extracted from formalin-fixed. paraffin-
embedded tissue. Briefly. an aliquot of 100-200 ng of genomic
DNA was amplified in a v-olume of 10 gl containing 50 nm\i potas-
sium chloride. 10 m\ Tris-HCl (pH 8.3). 1.5 mn\ magnesium chlo-
ride. 0.1 nmn of each dNTP. 10 pmol of each first set primer. 0.25
units of Taq DNA polymerase. The outer nested PCR amplifica-
tion was performed for 30 cycles with denaturation for 1 min at
Table 3 Correlation of apoptotic index with HPV infection and p53 mutation
Mean apoptofic index (± s.e.)
HPV Negative (n = 20) 2.48 (0.37)
Positive (n = 22) 2.23 (0.28)
p53* Wild-type (n = 26) 2.72 (0.28)
Mutant (n = 16) 1.73 (0.34)
Total 2.35 (0.23)
*P < 0.01 (Mtest for differences between tumours with wild-type and mutant
p53).
95CC. annealing for 1 min at each optimal temperature (55-C for
exon 8 outer. 58 C for exons 5. 5-6. 7 and 8 inner. 60-C for exon
6) and extension for 1 min at 72CC. An aliquot of 0.5 gl of the
product of this reaction was transferred to a second reaction
mixture containing the same medium as before. but with the inner
pair ofnested primers labelled with [r-'P]ATP A further 25 cycles
were carried out under the same conditions as above. Positise
controls from normal oral mucosa and blank- negative controls
Aw ere included in each reaction.
A 2-j1-aliquot of PCR products was diluted 10-fold with buffer
containin, 95%c formamide. 10 m- EDTA. 0.05% bromophenol
blue and 0.05% xylene cvanol. then heat-denatured at 98^C for
5 min followed by cooling on ice. An aliquot of 2-4 gl of this
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mixture was loaded into a 6%c non-denaturing polyacrylamide gel A
containing 5% glycerol and run at constant power of20 W for 6-8 h
under cooling with a fan at room temperature. Electrophoresis was
performed by using a sequencing-type apparatus (Bio-Rad
Laboratories. USA) using 0.5 x TBE as rumning buffer. Gels were
dried on filter paper andexposed toAgfa X-ray film with an intensi-
fying screen at - 70°C for 12-24 h. All the samples were subjected_
to duplicated ortriplicated reactions.
Detection of apoptosis by the TUNEL mrethod
The TUNEL method was perforned according to the description of
Gavnreli et al (1992). with slight modification. Briefly. afterdeparaf-
finization and hydration. sections were digested with 20jg ml-'
proteinase K at room temperature for 15 mum and endogenous
peroxidase was inactivatedbycovering with 2 hydrogen peroxide
for 5 min. Tissue sections were immersed in terminal deoxvnu-
cleotidvl transferase (TdT) buffer (30 n-Xi Tris-HCl. pH 7.2. 140 iNt--
sodium cacodylate. I inst cobalt chloride) at room temperature for
1Omn. and then incubated with 0.3 units pl-' TdT (Trevigen. i-
Maryland. USA) and 0.01 nmol 1-' biotin-Il-dUTP in TdT buffer
at 37°C for 60 mm. After washing wvith PBS. streptavidin peroxi-
dase was applied and finally the sections were visualized using
diaminobenzidine (DAB) and counterstained with 1% methyl green.
Normal lymph node tissues and reactions without TdT were used as
positive and negative controls respectively.
Al
The slide was randomly moved and five fields were selected and
photographed for each case (magnification x 400). All TUNEL
signal positive nuclei from at least 1000 tumour cells were then
counted. Apoptotic labelling indices were calculated as number of
positive cells per 100 tumour cells. c
Statistical analysis O
x
Statistical analysis was performed using the unpaired Student's t-
test. except for the correlations between HPV infection and p53
mutations. which were calculated using the chi-square test. A P-
value below 0.05 was considered significant. Data were presented
as mean ±s.e.
RESULTS
All 42 samples were histopathologically diagnosed as SCCs at
various grades of differentiation. The majonity of them were well
differentiated (69%). and the rest were moderately (21%) or
poorly differentiated (10%). DNA samples that gave no amplifica-
tion products for p53 were considered inadequate and excluded
from this studv. Figure 3 Apoptotic cells (arrows) in oral squamous cell carcinomas. A An
apoptotic cell charactenzed by a fewpyknotc apoptotic bodies separated
frorn the surrounding cells by a clear halo in haematoxylin and eosin sectons
HPV infection (orginal magnification x400). B Random distibubon ofTUNEL-positive
apoptotic cells in a well-differentiated carcinoma (original magnification
HPV DNA types 16. 18 and 33 wAere detected in the tumour tissues x 100). C Intense TUNEL signals in normal-kolong cells in well-differentiated
from 22 out of 42 patients (52%) with PCR and subsequent carcinoma (onginal magnification x40)
Southern blotting. Of these 22 HPV-positive samples. 15 cases
were infected with HPV type 16. six with HPV-18 and four with p53mutations
HPV-33. Two cases showed double infections with HPV-16 and
HPV-33 and one with HPV-16 and HPV-18. HPV-16 was the most p53 mutations in exons 5-8 were screened by nested PCR-SSCP
common virus type found in this group ofpatients and was present analysis. Altered mobilities ofthe amplified DNA. which suggests
in 68% (15/22) ofHPV-positiv%e tissues (Table 1. Figure 1). the existence of mutation. were observed in 16 of 42 tumours
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(38%). These 16 tumours had mutations in each of the analysed
exons as follows: exon 5 in six tumours, exon 6 in five tumours,
exon 7 in four tumours and exon 8 in four tumours. Among them.
two cases showed combined mutations in exonS and exon 6, one
case in exon 6 and exon 8 (Table 2, Figure 2).
p53 mutations were present in 10 of 22 HPV-positive carci-
nomas (45%) and six of 20 HPV-negative tumours (30%).
Fourteen carcinomas of 42 samples (33%) had neither HPV DNA
nor p53 alterations. The state of the p53 gene did not show any
correlation with HPV infection.
Ai
Cells undergoing apoptosis showed condensation of nuclear chro-
matin, nuclear fragnts (apoptotic bodies) and loss of cell-cell
contacts in routine H&E sections. TUNEL signals were randomly
distributed in tumour tissues. They were detected not only in
tumour cells showing chromatin condensation but also in morpho-
logically viable cells (non-pyknotic cells) at the start of apoptosis,
as identified by distinct nuclear staining (Figure 3). Non-
neoplastic epithelium was available adjacent to the tumour tissues
from 27 of 42 samples. TUNEL-positive cells were rarely
observed in the adjacent epithelium except in the most superficial
layer. which showed not only nuclear but also cytoplasmic
staining. It was difficult to determine whether these signals were
specific or not.
In 42 oral SCCs. the Al was averaged to be 2.35 ± 0.23 (s.e.),
ranging from 0.31 to 6.63. The mean Al was 2.72 ± 0.28 in 16
tumour samples with wild-type p53 and 1.73 ± 0.34 in those
with p53 mutation. This difference was statistically significant
(P < 0.01). There was, however, no difference in Als between
tumours with and without HPV infection (Table 3).
DISCUSSION
HPV DNAs have been found in various locations in the human
body and there is some certainty that HPVs play an important role
in carcinogenesis, especially in genital lesions (Herrington, 1995).
As oral mucosa is covered by squamous epithelium that resembles
cervical epithelium, it is important to investigate the relationship
between HPV infection and oral cancers. Many studies have
reported frequent association ofthe HPV in oral cancers, although
the exact nature of its relationship to oral carcinogenesis remains
obscure (Brachman et al, 1992; Barten et al, 1995).
We examined 42 oral SCCs for the presence ofHPV DNA using
PCR-Southem blot analysis with primers and probes specific for
HPV-16, -18 and -33, which have been detected frequently in
cervical carcinomas. HPV DNA sequences were identified in 22 of
42 samples (52%) with predominance of HPV-16 (15/22). This
finding is consistent with previous reports that have used PCR-
based methods to examine oral cancer tissues (Kiyabu et al. 1989;
Shindoh et al. 1992). The results of the present study indicate that
HPV infections are important but may not be sufficient for the
progression to malignancies and that synergistic actions with other
carcinogenic agents may be required. There is also an argument
against a singular role for HPV in oral carcinomas as some authors
reported high prevalence of HPV infection in a normal control
population (Jenison et al, 1990; Jalal et al. 1992). The possibility
cannot be excluded that HPV from adjacent normal or dysplastic
epithelium may have contributed. As compared with the epithe-
lium ofthe uterine cervix, the oral mucosa is continuously exposed
to a number of environmental carcinogens. including tobacco and
alcohol. Tlese factors may act synergistically with HPV. leading
to the development of carcinomas (Mao et al. 1996).
The p53 gene and its product have been studied extensively ever
since it became clear that more than 50% of human cancers
contain mutations in this gene, including carcinomas of the colon,
lung and breast (Levine, 1990; Hollstein et al, 1991a). p53
proteins encoded by mutant alleles are often more stable than wild-
type p53. resulting in a dramatic increase in p53 expression and
inactivation of wild-type p53 by a dominant-negative mechanism
(Levine, 1990; Weinberg, 1991). In addition to genetic change. an
altemative mechanism for the functional inactivation of p53 is the
formation of protein complexes with cellular proteins or viral
oncoproteins. HPV E6 and E7 proteins are consistently expressed
in HPV-transformed cells and in HPV-positive tumours, and the E6
protein fonms a complex with the p53 protein, resulting in degra-
dation of p53 (Scheffner et al, 1990; zur Hausen, 1994). This
targeted degradation of p53 by the E6 proteins would account for
the lowered levels of p53 protein found in HPV-immortalized
squamous epithelial cell lines (Scheffner et al, 1991).
The state of the p53 gene was investigated by SSCP analysis of
PCR products, which is a fast and sensitive method for detection of
sequence changes including single-base substitutions (Orita et al.
1989). Mutational analysis of the p53 gene was restricted to exons
5-8, where over 90% of the p53 mutations have been found in
other human malignancies (Hollstein et al. 1991a). In this study.
p53 gene mutations were detected in 16 of the 42 oral SCCs
(38%). This prevalence of mutations is similar to that reported in
studies of invasive head and neck carcinomas: 24% (Chiba et al,
1996) and 42% (Mao et al, 1996).
An interesting observation in this study was the frequent p53
mutations in HPV-positive oral carcinomas (10/22), suggesting
that HPV and p53 mutations may not be mutually exclusive
events. This is in contrast to the situation in cervical carcinomas, in
which mutations of the p53 gene appear to be rare in cases associ-
ated with HPV infection, but common in malignancies devoid of
HPV infection (Crook et al, 1991; Park et al. 1994). As co-expres-
sion of high-risk E6 protein together with wild-type p53 protein
can result in the same phenotypic effect as mutation of the p53
gene, inactivation ofthep53 gene by both mutation and binding to
the HPV oncoprotein E6 might seem unnecessary. But these two
factors may act on the same cell and cooperate with each other.
The presence of both HPV DNA and p53 mutations in the same
tumours in the present study provides some evidence for such
cooperation.
Apoptosis is a basic biological phenomenon of critical impor-
tance in the regulation of the cell population in situations as
diverse as embryonic growth and modelling, hormone-induced
organ involution and neoplasia (Kerr et al. 1972). We detected
apoptotic cells in oral SCCs by using the TUNEL method. Intense
TIJNEL signals were frequently observed in nuclei oftumour cells
showing chromatin condensation, and occasionally even in
ordinary, non-pyknotic nuclei of tumour cells. Grasl-Kraupp et al
(1995) reported that the TUNEL assay fails to distinguish apo-
ptosis from necrosis and should not be considered as a specific
method fordetecting apoptosis. In the present study, the possibility
was excluded by comparing theTllNEL-positive cells with histo-
logical findings, including inflammation in H&E-stained sections.
In the 42 oral SCCs, the mean Al (number ofapoptotic cells per
100 tumourcells) was 2.35 ± 0.23 (s.e.), ranging from 0.31 to 6.63.
This value is comparable with the Als determined in cancer of
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various locations, which ranged from 1.5 to 10.9 (Kasagi et al,
1994; Shoji et al, 1996; Tatebe et al, 1996). In relation to p53
status, SCCs associated withp53 mutation had significantly lower
Al than those with wild-type p53 (Table 3). These results suggest
that wild-type p53 may promote apoptosis and that mutant p53
might be involved in the inhibition ofapoptosis in oral SCCs. No
significant difference in Als was found between tumours with and
without HPV infection. But itcouldnot rule out the possibility that
HPV E6 protein may play a role in apoptosis as Als between
tumours with and without HPV infection were hampered by the
frequent p53 mutations in our study. Investigation of the HPV-
positive and -negative tumours without p53 mutation, in a large
series, will be required to determine whether this notion is correct.
There is increasing evidence that apoptosis may also be
involved in the progression ofcancer, although conflicting results
have been reported regarding AI and patient prognosis (Kasagi
et al, 1994; Tormanen et al, 1995). Theoretically, an increase in
apoptosis may result in tumour regression, but some authors have
proposed that apoptosis may reflect not only cell loss but also the
proliferative activity ofthe cancer (Tatebe et al, 1996). Additional
studies will determine if detection of apoptosis can be used as a
prognostic parameter for the oral cancer.
In conclusion, this study confirms that HPV infection and/or
p53 mutations are implicated, but are not mutually exclusive
events, in carcinogenesis of oral SCC. The results also show that
decrease in apoptosis in oral cancer is more closely related top53
mutation than HPV infection. Further study is necessary to define
the exact role of apoptosis in differentiation and progression of
carcinoma and prognostic value ofAl in oral cancers.
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